BioMarin Pharmaceutical Inc. (BMRN)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 85.59 |
| Open | 85.71 |
| Bid | 84.45 x 200 |
| Ask | 84.61 x 100 |
| Day's range | 84.07 - 86.45 |
| 52-week range | 73.68 - 99.56 |
| Volume | |
| Avg. volume | 2,479,761 |
| Market cap | 16.062B |
| Beta (5Y monthly) | 0.32 |
| PE ratio (TTM) | 79.80 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
The Zacks Analyst Blog Highlights Sage Therapeutics, Biogen Agenus and BioMarin Pharmaceutical
Sage Therapeutics, Biogen Agenus and BioMarin Pharmaceutical are part of the Zacks top Analyst Blog.
- Zacks
Why BioMarin (BMRN) is Poised to Beat Earnings Estimates Again
BioMarin (BMRN) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
- Zacks
Analysts Estimate Repligen (RGEN) to Report a Decline in Earnings: What to Look Out for
Repligen (RGEN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
© 2024 Yahoo. All rights reserved.